Publications by authors named "Marc Debled"

77Publications

Residual cancer burden index and tumor-infiltrating lymphocyte subtypes in triple-negative breast cancer after neoadjuvant chemotherapy.

Breast Cancer Res Treat 2020 Jan 16;179(1):11-23. Epub 2019 Sep 16.

Department of Biopathology, Institut Bergonié, Comprehensive Cancer Center, 229 Cours de l'Argonne CS61283-33076, 33000, Bordeaux, Cedex, France.

View Article and Find Full Text PDF
January 2020

Deprivation and mass screening: Survival of women diagnosed with breast cancer in France from 2008 to 2010.

Cancer Epidemiol 2019 06 20;60:149-155. Epub 2019 Apr 20.

Univ. Bordeaux, Gironde General Cancer Registry, 33000, Bordeaux, France; Inserm, Bordeaux Population Health, Research Center U1219, Team Epicene, 33000, Bordeaux, France; Univ. Bordeaux, ISPED, 33000, Bordeaux, France. Electronic address:

View Article and Find Full Text PDF
June 2019

Subcutaneous auto-administration of trastuzumab following therapeutic education: A case report.

J Oncol Pharm Pract 2019 Sep 20;25(6):1523-1525. Epub 2018 Aug 20.

1 Department of Pharmacy, Institut Bergonié, Bordeaux, France.

View Article and Find Full Text PDF
September 2019

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.

N Engl J Med 2018 Jul 4;379(2):122-137. Epub 2018 Jun 4.

From the Peter MacCallum Cancer Centre, St. Vincent's Hospital, University of Melbourne, Melbourne, VIC, and Breast Cancer Trials Australia and New Zealand, University of Newcastle, Newcastle, NSW (P.A.F.), and the University of Sydney, Sydney (A.S.C.) - all in Australia; the Institute of Oncology of Southern Switzerland, Ospedale San Giovanni, Bellinzona (O.P.), Breast Cancer St. Gallen, St. Gallen (T.R.), and the International Breast Cancer Study Group Coordinating Center (R.M., M.R.-P., B.R., A.S.C.), University Hospital Inselspital (M.R.-P.), Bern - all in Switzerland; the University of Chicago Medical Center, Chicago (G.F.F.); the University of Calgary, Calgary, AB, Canada (B.A.W.); the Division of Medical Senology, European Institute of Oncology (M.C.), and the European Institute of Oncology and International Breast Cancer Study Group (A.G.), Milan, Ospedale Papa Giovanni XXIII, Bergamo (C.T.), Azienda Socio Sanitaria Territoriale Sette Laghi-Ospedale di Circolo and Fondazione Macchi, Varese (G.P.), Medical Oncology and Cancer Prevention, IRCCS, National Cancer Institute, Aviano (F.P., S.S.), the Department of Medicine, School of Medical Oncology, University of Udine, Udine (F.P.), Salvatore Maugeri Foundation, Pavia (L.P.), and the Hospital of Prato-Azienda Unità Sanitaria Locale Toscana Centro, Prato (A.D.L.) - all in Italy; the National Institute of Oncology, Budapest, Hungary (I.L.); Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru (H.L.G.); University Hospital 12 de Octubre, Madrid (E.C.), Vall d'Hebron Institute of Oncology and Vall d'Hebron University Hospital, Barcelona (M.B.), and Instituto Valenciano de Oncologia, Valencia (M.A.C.) - all in Spain; the Susan F. Smith Center for Women's Cancers (H.J.B., E.P.W.) and the International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology (R.D.G., M.M.R.), Dana-Farber Cancer Institute, Harvard Medical School, the Harvard T.H. Chan School of Public Health, and Frontier Science and Technology Research Foundation (R.D.G.) - all in Boston; Institut Bergonié Comprehensive Cancer Center, Université de Bordeaux, Bordeaux, France (H.R.B., M.D.); the Angeles Clinic and Research Institute, Santa Monica, CA (S.M.); Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond (C.E.G.); Mayo Clinic, Rochester, MN (M.P.G., J.N.I.); Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore (V.S.); Fred Hutchinson Cancer Research Center, University of Washington, Seattle (N.E.D.); Weston Park Hospital, Sheffield, United Kingdom (R.C.); and the Department of Obstetrics and Gynecology, University Medical Center, Regensburg, Germany (S.B.).

View Article and Find Full Text PDF
July 2018

[Breast reconstruction in elderly patients: Studies of the practices at institut Bergonié during 2005-2015].

Bull Cancer 2017 Jun 16;104(6):508-515. Epub 2017 May 16.

Institut Bergonié, département de chirurgie, 229, cours de l'Argonne, 33000 Bordeaux, France. Electronic address:

View Article and Find Full Text PDF
June 2017

Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study.

J Clin Oncol 2017 Apr 13;35(11):1179-1188. Epub 2017 Feb 13.

Signe Borgquist and Judy E. Garber, Dana-Farber Cancer Institute, Harvard Medical School; Anita Giobbie-Hurder, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute; Richard D. Gelber, IBCSG Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, T.H. Chan Harvard School of Public Health, and Frontier Science and Technology Research Foundation; Karen N. Price, IBCSG Statistical Center and Frontier Science and Technology Research Foundation; Meredith M. Regan, IBCSG Statistical Center, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA; Signe Borgquist, Lund University, Lund, Sweden; Thomas P. Ahern, University of Vermont, Burlington, VT; Marco Colleoni and Aron Goldhirsch, IBCSG and European Institute of Oncology, Milan, Italy; István Láng, IBCSG and National Institute of Oncology, Budapest, Hungary; Marc Debled, Institut Bergonié, Bordeaux, France; Bent Ejlertsen, Danish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen, Denmark; Roger von Moos, Cantonal Hospital Graubuenden, Chur; Swiss Group for Clinical Cancer Research and IBCSG; Manuela Rabaglio, IBCSG Coordinating Center and Inselspital, Bern; Beat Thürlimann, Breast Center St. Gallen, Kantonsspital, St. Gallen; Swiss Group for Clinical Cancer Research and IBCSG, Bern, Switzerland; Ian Smith, The Royal Marsden Hospital, London, United Kingdom; and Alan S. Coates, IBCSG and University of Sydney School of Public Health, Sydney, Australia.

View Article and Find Full Text PDF
April 2017

Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence.

J Clin Oncol 2016 07 23;34(21):2452-9. Epub 2016 May 23.

Jacquie H. Chirgwin and John F. Forbes, University of Newcastle; John F. Forbes, Calvary Mater Newcastle, Newcastle; Alan S. Coates, University of Sydney School of Public Health, Sydney, New South Wales; Jacquie H. Chirgwin, Box Hill Hospital; Jacquie H. Chirgwin, Maroondah Hospital; Jacquie H. Chirgwin, Monash University, Melbourne, Victoria, Australia; Anita Giobbie-Hurder, Karen N. Price, and Richard D. Gelber, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute; Karen N. Price and Richard D. Gelber, Frontier Science and Technology Research Foundation; Richard D. Gelber, Harvard Medical School, Boston, MA; Bent Ejlertsen, Rigshospitalet, Copenhagen, Denmark; Marc Debled, Institut Bergonié, Bordeaux, France; Aron Goldhirsch and Marco Colleoni, European Institute of Oncology, Milan, Italy; Ian Smith, The Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom; Manuela Rabaglio, Inselspital, Bern; Beat Thürlimann, Kantonsspital, St. Gallen, Switzerland; Patrick Neven, University of Leuven; Patrick Neven, University Hospitals Leuven, Leuven, Belgium; István Láng, National Institute of Oncology, Budapest, Hungary.

View Article and Find Full Text PDF
July 2016

A 21-Gene Expression Assay in Breast Cancer.

N Engl J Med 2016 04;374(14):1385-6

Institut Bergonié, Bordeaux, France

View Article and Find Full Text PDF
April 2016

Comprehensive prognostic analysis in breast cancer integrating clinical, tumoral, micro-environmental and immunohistochemical criteria.

Springerplus 2015 21;4:528. Epub 2015 Sep 21.

Department of BioPathology, Institut Bergonié, 229, cours de l'Argonne, 33076 Bordeaux, France ; Institut National de la Santé et de la Recherche Médicale (INSERM) U916, Institut Bergonié, 229 cours de l'Argonne, 33076 Bordeaux, France.

View Article and Find Full Text PDF
September 2015

High-throughput pharmacogenetics identifies SLCO1A2 polymorphisms as candidates to elucidate the risk of febrile neutropenia in the breast cancer RAPP-01 trial.

Breast Cancer Res Treat 2015 Sep 29;153(2):383-9. Epub 2015 Aug 29.

Institut Curie, Service de Génétique, Unité de Pharmacogénomique, 26 rue d'Ulm, 75005, Paris, France,

View Article and Find Full Text PDF
September 2015

Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial.

J Clin Oncol 2015 Sep 27;33(25):2772-9. Epub 2015 Jul 27.

Otto Metzger Filho, Anita Giobbie-Hurder, and Eric P. Winer, Dana-Farber Cancer Institute; Richard D. Gelber and Meredith M. Regan, Harvard Medical School; Karen N. Price, Frontier Science and Technology Research, Boston, MA; Elizabeth Mallon, Southern General Hospital; Barry Gusterson, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom; Giuseppe Viale, European Institute of Oncology and University of Milan; Marco Colleoni and Aron Goldhirsch, European Institute of Oncology, Milan, Italy; Beat Thürlimann, Kantonsspital, St. Gallen, and Swiss Group for Clinical Cancer Research, Bern, Switzerland; Bent Ejlertsen, Rigshospitalet, Copenhagen, Denmark; Marc Debled, Institut Bergoniié, Bordeaux, France; and Alan S. Coates, International Breast Cancer Study Group, Bern, Switzerland, and University of Sydney, Sydney, Australia.

View Article and Find Full Text PDF
September 2015

Single-Centre Experience with Percutaneous Cryoablation of Breast Cancer in 23 Consecutive Non-surgical Patients.

Cardiovasc Intervent Radiol 2015 Oct 17;38(5):1237-43. Epub 2015 Jul 17.

Department of Medical Imaging, Institut Bergonié, Comprehensive Cancer Centre, 229 cours de l'Argonne, 33000, Bordeaux, France.

View Article and Find Full Text PDF
October 2015

[Genomic signature of breast cancer: The quest for the Holy Grail].

Bull Cancer 2015 Jun;102(6 Suppl 1):S106-10

Département de biopathologie, Institut Bergonié, Bordeaux, France.

View Article and Find Full Text PDF
June 2015

[Oncofertility and breast cancer: Where have we come from, where are we going?].

Bull Cancer 2015 Jun 16;102(6):489-96. Epub 2015 May 16.

Institut de lutte contre le cancer, institut Bergonié, service de chirurgie, Bordeaux, France. Electronic address:

View Article and Find Full Text PDF
June 2015

Accumulation of an endogenous tryptophan-derived metabolite in colorectal and breast cancers.

PLoS One 2015 16;10(4):e0122046. Epub 2015 Apr 16.

Macquarie University, Faculty of Medicine, Neuroinflammation group, Sydney, New South Wales, Australia; Applied Neurosciences Program, Peter Duncan Neurosciences Research Unit, St Vincent's Centre for Applied Medical Research, Darlinghurst, New South Wales, Australia.

View Article and Find Full Text PDF
January 2016

[Should knowledge of BRCA1 status impact the choice of chemotherapy in metastatic breast cancer: a review].

Bull Cancer 2015 Mar 7;102(3):245-55. Epub 2015 Mar 7.

Institut Bergonié, département d'oncologie médicale, 33076 Bordeaux cedex, France. Electronic address:

View Article and Find Full Text PDF
March 2015

Complete response to exemestane in a patient with a desmoid tumor.

Future Oncol 2012 Apr;8(4):483-6

Department of Medical Oncology, Institut Bergonié, 229 cours de l'Argonne, 33076 Bordeaux Cedex, France.

View Article and Find Full Text PDF
April 2012

Capecitabine monotherapy: review of studies in first-line HER-2-negative metastatic breast cancer.

Oncologist 2012 14;17(4):476-84. Epub 2012 Mar 14.

Baylor-Sammons Cancer Center, Texas Oncology, US Oncology, 3535 Worth Street, Collins 5, Dallas, Texas 75246, USA.

View Article and Find Full Text PDF
October 2012

[Medical treatments of endocrine-sensitive Her-2 negative breast cancers: a review].

Bull Cancer 2011 Jun;98(6):655-70

Institut Bergonié, département d'oncologie médicale, Bordeaux Cedex, France.

View Article and Find Full Text PDF
June 2011

Chemotherapy treatment for older women with metastatic breast cancer: what is the evidence?

Cancer Treat Rev 2011 Dec 17;37(8):590-8. Epub 2011 May 17.

Department of Medical Oncology, Institut Bergonié, South-West Comprehensive Cancer Center, Bordeaux Cedex, France.

View Article and Find Full Text PDF
December 2011

First-line chemotherapy for metastatic breast cancer in patients ≥75 years: a retrospective single-centre analysis.

Crit Rev Oncol Hematol 2011 Oct 29;80(1):171-9. Epub 2010 Oct 29.

Institut Bergonié, South-West Comprehensive Cancer Center, Bordeaux, France.

View Article and Find Full Text PDF
October 2011

Variables with time-varying effects and the Cox model: some statistical concepts illustrated with a prognostic factor study in breast cancer.

BMC Med Res Methodol 2010 Mar 16;10:20. Epub 2010 Mar 16.

Department of Clinical Epidemiology and Clinical Research, Institut Bergonié, Regional Comprehensive Cancer Centre, Bordeaux, France.

View Article and Find Full Text PDF
March 2010

First-line capecitabine monotherapy for slowly progressing metastatic breast cancer: do we need aggressive treatment?

Oncology 2009 23;77(5):318-27. Epub 2009 Nov 23.

Department of Medical Oncology, Institut Bergonié, South-West Comprehensive Cancer Center, Bordeaux, France. debled @ bergonie.org

View Article and Find Full Text PDF
January 2010

[Interventional radiology procedures in the treatment of bone metastasis].

Bull Cancer 2009 Nov;96(11):1117-26

Départements d'imagerie, centre régional de lutte contre cancer, institut Bergonié, 229, cours de l'Argonne, 33076 Bordeaux cedex, France.

View Article and Find Full Text PDF
November 2009

[Breast cancer in the elderly].

Bull Cancer 2008 May;95 FMC Onco:F51-6

Département d'oncologie médicale, Centre René-Huguenin, 35, rue Dailly, 92210 Saint-Cloud et Programme d'action concertée Gerico de la Fédération nationale des centres de lutte contre le cancer, 101, rue de Tolbiac, 75654 Paris Cedex 13, France.

View Article and Find Full Text PDF
May 2008

D2-40 in breast cancer: should we detect more vascular emboli?

Mod Pathol 2009 Feb 26;22(2):216-22. Epub 2008 Sep 26.

Department of Pathology, Institut Bergonié, Regional Cancer Center, Bordeaux, France.

View Article and Find Full Text PDF
February 2009

When will more useful predictive factors be ready for use?

Breast 2005 Dec 16;14(6):617-23. Epub 2005 Sep 16.

Department of Medical Oncology, Institut Bergonié, Regional Cancer Center, 229 cours de l'Argonne, 33076 Bordeaux Cedex, France.

View Article and Find Full Text PDF
December 2005